Waldenstrom's Macroglobulinemia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Observational Study of Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors
Conditions: Chronic Lymphocytic Leukemia (CLL); Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia; Mantle Cell Lymphoma; Sudden Cardiac Death; Cardiac Arrhythmias; Hematologic Malignancies Intervention: Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2023 Category: Research Source Type: clinical trials
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenstr öm Macroglobulinemia
Condition: Waldenstrom Macroglobulinemia Intervention: Drug: Zanubrutinib Sponsor: BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2022 Category: Research Source Type: clinical trials
